{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:17:24Z","timestamp":1785863844555,"version":"3.56.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00228-022-03297-z","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T23:02:27Z","timestamp":1645657347000},"page":"907-917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Desmopressin therapy in children and adults: pharmacological considerations and clinical implications"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-0930","authenticated-orcid":false,"given":"Xinyi","family":"Chin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao Wei","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Ting","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8884-1805","authenticated-orcid":false,"given":"Yong Hong","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"How Chuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1083-7958","authenticated-orcid":false,"given":"Fabian","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"3297_CR1","doi-asserted-by":"publisher","unstructured":"Acher R, Chauvet J, Chauvet M-T, Crepy D (1965) Caracterisation des hormones neurohypophysaires d'un poisson osseux d'eau douce, la carpe (Cyprinus carpio). Comparaison avec les hormones des poissons osseux marins. Comp Biochem Physiol\u00a014(2):245\u201354. https:\/\/doi.org\/10.1016\/0010-406X(65)90201-X","DOI":"10.1016\/0010-406X(65)90201-X"},{"key":"3297_CR2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1135\/cccc19671250","volume":"32","author":"M Zaoral","year":"1967","unstructured":"Zaoral M, Kole J, Sorm F (1967) Synthesis of 1-deamino-8-D-amino-butyrine vasopressin, 1-deamino-8-D-lysine vasopressin and 1-deamino-8-D-arginine vasopressin. Collection of Czechoslovak Chemistry Communications 32:1250\u20131257","journal-title":"Collection of Czechoslovak Chemistry Communications"},{"issue":"3","key":"3297_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/bip.20936","volume":"90","author":"M Zaoral","year":"2008","unstructured":"Zaoral M (2008) DDAVP (Desmopressin) and solid phase peptide synthesis. Pept Sci 90(3):213. https:\/\/doi.org\/10.1002\/bip.20936","journal-title":"Pept Sci"},{"issue":"8024","key":"3297_CR4","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(77)92467-9","volume":"1","author":"SB Dimson","year":"1977","unstructured":"Dimson SB (1977) Desmopressin as a treatment for enuresis. Lancet (London, England) 1(8024):1260. https:\/\/doi.org\/10.1016\/S0140-6736(77)92467-9","journal-title":"Lancet (London, England)"},{"issue":"3","key":"3297_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2174\/157488607781668891","volume":"2","author":"J Vande Walle","year":"2007","unstructured":"Vande Walle J, Stockner M, Raes A, Norgaard JP (2007) Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf 2(3):232\u2013238. https:\/\/doi.org\/10.2174\/157488607781668891","journal-title":"Curr Drug Saf"},{"key":"3297_CR6","doi-asserted-by":"publisher","unstructured":"Safety concerns prompt update to US labelling for desmopressin (2007) Inpharma Weekly 1617(1):17. https:\/\/doi.org\/10.2165\/00128413-200716170-00051","DOI":"10.2165\/00128413-200716170-00051"},{"key":"3297_CR7","unstructured":"MHRA (2007) Desmopressin nasal spray: removal of nocturnal enuresis indication. Drug Safety Update 1(2):7. https:\/\/www.gov.uk\/drug-safety-update\/desmopressin-nasal-spray-removal-of-nocturnal-enuresis-indication. Accessed 10 Oct\u00a02021"},{"key":"3297_CR8","unstructured":"Truax BT (2016) Patient safety tip of the week: desmopressin back in the spotlight. https:\/\/www.patientsafetysolutions.com\/docs\/October_25_2016_Desmopressin_Back_in_the_Spotlight.pdf. Accessed 10 Oct\u00a02021"},{"issue":"4","key":"3297_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/bjaceaccp\/mkn021","volume":"8","author":"A Sharman","year":"2008","unstructured":"Sharman A, Low J (2008) Vasopressin and its role in critical care. Continuing Education in Anaesthesia Critical Care & Pain 8(4):134\u2013137. https:\/\/doi.org\/10.1093\/bjaceaccp\/mkn021","journal-title":"Continuing Education in Anaesthesia Critical Care & Pain"},{"issue":"4","key":"3297_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0036-1583282","volume":"5","author":"K Choong","year":"2016","unstructured":"Choong K (2016) Vasopressin in pediatric critical care. Journal of Pediatric Intensive Care 5(4):182\u2013188. https:\/\/doi.org\/10.1055\/s-0036-1583282","journal-title":"Journal of Pediatric Intensive Care"},{"key":"3297_CR11","doi-asserted-by":"crossref","unstructured":"Phelps SJ, Hagemann TM, Lee KR, Thompson AJ (2018) Vasopressin. Pediatric injectable drugs (The Teddy Bear Book). 11th edition: Am Soc Health Syst Pharm\u00a0860\u20133","DOI":"10.37573\/9781585285402.238"},{"key":"3297_CR12","first-page":"115","volume":"2","author":"RJ Kim","year":"2004","unstructured":"Kim RJ, Malattia C, Allen M, Moshang JT, Maghnie M (2004) Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations. Pediatr Endocrinol Rev 2:115\u2013123","journal-title":"Pediatr Endocrinol Rev"},{"issue":"11\u201312","key":"3297_CR13","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1515\/jpem-2013-0026","volume":"26","author":"A Karthikeyan","year":"2013","unstructured":"Karthikeyan A, Abid N, Sundaram PC, Shaw NJ, Barrett TG, H\u00f6gler W et al (2013) Clinical characteristics and management of cranial diabetes insipidus in infants. J Pediatr Endocrinol Metab 26(11\u201312):1041\u20131046. https:\/\/doi.org\/10.1515\/jpem-2013-0026","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"3297_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/cen.14125","volume":"92","author":"WY Lim","year":"2019","unstructured":"Lim WY, Riba-Wolman R (2019) Intravenous formulation of desmopressin delivered via oral and g tube routes for the treatment of central diabetes insipidus: first experience in infants. Clin Endocrinol 92(2):179\u2013181. https:\/\/doi.org\/10.1111\/cen.14125","journal-title":"Clin Endocrinol"},{"issue":"9\u201310","key":"3297_CR15","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1515\/jpem-2013-0368","volume":"27","author":"HA Korkmaz","year":"2014","unstructured":"Korkmaz HA, Demir K, K\u0131l\u0131\u00e7 FK, Terek D, Arslano\u011flu S, Dizdarer C et al (2014) Management of central diabetes insipidus with oral desmopressin lyophilisate in infants. J Pediatr Endocrinol Metab 27(9\u201310):923\u2013927. https:\/\/doi.org\/10.1515\/jpem-2013-0368","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"3297_CR16","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1210\/jc.2016-1157","volume":"101","author":"AR Smego","year":"2016","unstructured":"Smego AR, Backeljauw P, Gutmark-Little I (2016) Buccally administered intranasal desmopressin acetate for the treatment of neurogenic diabetes insipidus in infancy. J Clin Endocrinol Metab 101(5):2084\u20132088. https:\/\/doi.org\/10.1210\/jc.2016-1157","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3297_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1515\/jpem-2017-0051","volume":"30","author":"M Mavinkurve","year":"2017","unstructured":"Mavinkurve M, McGrath N, Johnston N, Moloney S, Murphy NP, Hawkes CP (2017) Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus. J Pediatr Endocrinol Metab 30(6):623\u2013628. https:\/\/doi.org\/10.1515\/jpem-2017-0051","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"3297_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4158\/EP.2.5.353","volume":"2","author":"JA Durr","year":"1996","unstructured":"Durr JA, Lindheimer MD (1996) Diagnosis and management of diabetes insipidus during pregnancy. Endocr Pract 2(5):353\u2013361. https:\/\/doi.org\/10.4158\/EP.2.5.353","journal-title":"Endocr Pract"},{"issue":"2","key":"3297_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.beem.2016.02.005","volume":"30","author":"S Ananthakrishnan","year":"2016","unstructured":"Ananthakrishnan S (2016) Diabetes insipidus during pregnancy. Best Pract Res Clin Endocrinol Metab 30(2):305\u2013315. https:\/\/doi.org\/10.1016\/j.beem.2016.02.005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"3297_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0950-3552(05)80323-2","volume":"8","author":"MD Lindheimer","year":"1994","unstructured":"Lindheimer MD, Barron WM (1994) Water metabolism and vasopressin secretion during pregnancy. Baillieres Clin Obstet Gynaecol 8(2):311\u2013331. https:\/\/doi.org\/10.1016\/S0950-3552(05)80323-2","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"3297_CR21","doi-asserted-by":"publisher","unstructured":"Marques P, Gunawardana K, Grossman A (2015) Transient diabetes insipidus in pregnancy. Endocrinol Diabetes Metab Case Rep\u00a02015(1). https:\/\/doi.org\/10.1530\/EDM-15-0078","DOI":"10.1530\/EDM-15-0078"},{"issue":"586","key":"3297_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3399\/bjgp11X572562","volume":"61","author":"N O'Flynn","year":"2011","unstructured":"O\u2019Flynn N (2011) Nocturnal enuresis in children and young people: NICE clinical guideline. Br J Gen Pract 61(586):360\u2013362. https:\/\/doi.org\/10.3399\/bjgp11X572562","journal-title":"Br J Gen Pract"},{"issue":"2","key":"3297_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.juro.2009.10.043","volume":"183","author":"T Neveus","year":"2010","unstructured":"Neveus T, Eggert P, Evans J, Macedo A, Rittig S, Tekg\u00fcl S et al (2010) Evaluation of and treatment for monosymptomatic enuresis: a standardization document from the International Children\u2019s Continence Society. J Urol 183(2):441\u2013447. https:\/\/doi.org\/10.1016\/j.juro.2009.10.043","journal-title":"J Urol"},{"key":"3297_CR24","doi-asserted-by":"publisher","unstructured":"Hj\u00e4lm\u00e5s K, Hanson E, Hellstr\u00f6m A, Kruse S, Sillen U (1998) Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group. Br J Urol 82(5):704\u20139. https:\/\/doi.org\/10.1046\/j.1464-410x.1998.00826.x","DOI":"10.1046\/j.1464-410x.1998.00826.x"},{"issue":"12","key":"3297_CR25","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1097\/01.chi.0000142196.41215.cc","volume":"43","author":"G Fritz","year":"2004","unstructured":"Fritz G, Rockney R (2004) Practice parameter for the assessment and treatment of children and adolescents with enuresis. J Am Acad Child Adolesc Psychiatry 43(12):1540\u20131550. https:\/\/doi.org\/10.1097\/01.chi.0000142196.41215.cc","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"3297_CR26","doi-asserted-by":"publisher","first-page":"16755","DOI":"10.1038\/s41598-018-34935-1","volume":"8","author":"CCH Peng","year":"2018","unstructured":"Peng CCH, Yang SSD, Austin PF, Chang SJ (2018) Systematic review and meta-analysis of alarm versus desmopressin therapy for pediatric monosymptomatic enuresis. Sci Rep 8(1):16755. https:\/\/doi.org\/10.1038\/s41598-018-34935-1","journal-title":"Sci Rep"},{"issue":"1","key":"3297_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.juro.2007.03.015","volume":"178","author":"W Robson","year":"2007","unstructured":"Robson W, Leung A, Norgaard JP (2007) The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis. J Urol 178(1):24\u201330. https:\/\/doi.org\/10.1016\/j.juro.2007.03.015","journal-title":"J Urol"},{"issue":"2","key":"3297_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/nau.23917","volume":"38","author":"H Hashim","year":"2019","unstructured":"Hashim H, Blanker MH, Drake MJ, Djurhuus JC, Meijlink J, Morris V et al (2019) International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn 38(2):499\u2013508. https:\/\/doi.org\/10.1002\/nau.23917","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"3297_CR29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1532-5415.2010.02822.x","volume":"58","author":"KL Burgio","year":"2010","unstructured":"Burgio KL, Johnson TM II, Goode PS, Markland AD, Richter HE, Roth DL et al (2010) Prevalence and correlates of nocturia in community-dwelling older adults. J Am Geriatr Soc 58(5):861\u2013866. https:\/\/doi.org\/10.1111\/j.1532-5415.2010.02822.x","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"3297_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.juro.2010.09.108","volume":"185","author":"V Kupelian","year":"2011","unstructured":"Kupelian V, Fitzgerald MP, Kaplan SA, Norgaard JP, Chiu GR, Rosen RC (2011) Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol 185(2):571\u2013577. https:\/\/doi.org\/10.1016\/j.juro.2010.09.108","journal-title":"J Urol"},{"issue":"2","key":"3297_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.smrv.2010.03.002","volume":"15","author":"S Ancoli-Israel","year":"2011","unstructured":"Ancoli-Israel S, Bliwise DL, N\u00f8rgaard JP (2011) The effect of nocturia on sleep. Sleep Med Rev 15(2):91\u201397. https:\/\/doi.org\/10.1016\/j.smrv.2010.03.002","journal-title":"Sleep Med Rev"},{"key":"3297_CR32","unstructured":"Leslie SW, Sajjad H, Singh S (2020) Nocturia. StatPearls [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK518987\/. Accessed 10 Oct 2021"},{"issue":"1","key":"3297_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eururo.2011.05.065","volume":"61","author":"V Kupelian","year":"2012","unstructured":"Kupelian V, Wei JT, O\u2019Leary MP, Norgaard JP, Rosen RC, McKinlay JB (2012) Nocturia and quality of life: results from the Boston area community health survey. Eur Urol 61(1):78\u201384. https:\/\/doi.org\/10.1016\/j.eururo.2011.05.065","journal-title":"Eur Urol"},{"issue":"4","key":"3297_CR34","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.juro.2011.05.083","volume":"186","author":"JP Weiss","year":"2011","unstructured":"Weiss JP, van Kerrebroeck PE, Klein BM, N\u00f8rgaard JP (2011) Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia. J Urol 186(4):1358\u20131363. https:\/\/doi.org\/10.1016\/j.juro.2011.05.083","journal-title":"J Urol"},{"issue":"7","key":"3297_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.acuroe.2011.03.002","volume":"35","author":"JW Th\u00fcroff","year":"2011","unstructured":"Th\u00fcroff JW, Abrams P, Andersson K-E, Artibani W, Chapple CR, Drake MJ et al (2011) EAU guidelines on urinary incontinence. Actas Urol\u00f3gicas Espa\u00f1olas (English Edition) 35(7):373\u2013388. https:\/\/doi.org\/10.1016\/j.acuroe.2011.03.002","journal-title":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"},{"issue":"1","key":"3297_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1464-410X.2011.10175.x","volume":"108","author":"JP Weiss","year":"2011","unstructured":"Weiss JP, Blaivas JG, Bliwise DL, Dmochowski RR, DuBeau CE, Lowe FC et al (2011) The evaluation and treatment of nocturia: a consensus statement. BJU Int 108(1):6\u201321. https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10175.x","journal-title":"BJU Int"},{"issue":"1","key":"3297_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/nau.20870","volume":"29","author":"P Abrams","year":"2010","unstructured":"Abrams P, Andersson K-E, Birder L, Brubaker L, Cardozo L, Chapple C et al (2010) Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourology and Urodynamics: Official Journal of the International Continence Society 29(1):213\u2013240. https:\/\/doi.org\/10.1002\/nau.20870","journal-title":"Neurourology and Urodynamics: Official Journal of the International Continence Society"},{"issue":"3","key":"3297_CR38","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.juro.2012.12.112","volume":"190","author":"JP Weiss","year":"2013","unstructured":"Weiss JP, Herschorn S, Albei CD, van der Meulen EA (2013) Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol 190(3):965\u2013972. https:\/\/doi.org\/10.1016\/j.juro.2012.12.112","journal-title":"J Urol"},{"issue":"3","key":"3297_CR39","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.juro.2013.02.037","volume":"190","author":"PK Sand","year":"2013","unstructured":"Sand PK, Dmochowski RR, Reddy J, van der Meulen EA (2013) Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol 190(3):958\u2013964. https:\/\/doi.org\/10.1016\/j.juro.2013.02.037","journal-title":"J Urol"},{"issue":"5","key":"3297_CR40","doi-asserted-by":"publisher","first-page":"F1116","DOI":"10.1152\/ajprenal.00741.2010","volume":"300","author":"KV Juul","year":"2011","unstructured":"Juul KV, Klein BM, Sandstr\u00f6m R, Erichsen L, N\u00f8rgaard JP (2011) Gender difference in antidiuretic response to desmopressin. American Journal of Physiology-Renal Physiology 300(5):F1116\u2013F1122","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"3","key":"3297_CR41","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1464-410X.2012.11547.x","volume":"111","author":"O Yamaguchi","year":"2013","unstructured":"Yamaguchi O, Nishizawa O, Juul KV, N\u00f8rgaard JP (2013) Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. BJU Int 111(3):474\u2013484. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11547.x","journal-title":"BJU Int"},{"issue":"2","key":"3297_CR42","doi-asserted-by":"publisher","first-page":"F433","DOI":"10.1152\/ajprenal.00199.2010","volume":"300","author":"J Liu","year":"2010","unstructured":"Liu J, Sharma N, Zheng W, Ji H, Tam H, Wu X et al (2010) Sex differences in vasopressin V2 receptor expression and vasopressin-induced antidiuresis. Am J Physiol Ren Physiol 300(2):F433\u2013F440. https:\/\/doi.org\/10.1152\/ajprenal.00199.2010","journal-title":"Am J Physiol Ren Physiol"},{"issue":"7031","key":"3297_CR43","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature03479","volume":"434","author":"L Carrel","year":"2005","unstructured":"Carrel L, Willard HF (2005) X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434(7031):400\u2013404. https:\/\/doi.org\/10.1038\/nature03479","journal-title":"Nature"},{"issue":"3","key":"3297_CR44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4236\/ojped.2013.33039","volume":"3","author":"KJ Vinter","year":"2013","unstructured":"Vinter KJ, Goble S, De Bruyne P, Vande Walle J, N\u00f8rgaard JP (2013) Is there a gender difference in antidiuretic response to desmopressin in children? Open Journal of Pediatrics 3(3):224\u2013230. https:\/\/doi.org\/10.4236\/ojped.2013.33039","journal-title":"Open Journal of Pediatrics"},{"issue":"2","key":"3297_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1507\/endocrj.EJ14-0368","volume":"62","author":"Y Kataoka","year":"2015","unstructured":"Kataoka Y, Nishida S, Hirakawa A, Oiso Y, Arima H (2015) Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus. Endocr J 62(2):195\u2013200. https:\/\/doi.org\/10.1507\/endocrj.EJ14-0368","journal-title":"Endocr J"},{"issue":"4","key":"3297_CR46","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.16120","volume":"12","author":"K De Waele","year":"2014","unstructured":"De Waele K, Cools M, De Guchtenaere A, Van de Walle J, Raes A, Van Aken S et al (2014) Desmopressin lyophilisate for the treatment of central diabetes insipidus: first experience in very young infants. International Journal of Endocrinology and Metabolism 12(4):e16120. https:\/\/doi.org\/10.5812\/ijem.16120","journal-title":"International Journal of Endocrinology and Metabolism"},{"issue":"4","key":"3297_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2165\/11319110-000000000-00000","volume":"33","author":"J Van de Walle","year":"2010","unstructured":"Van de Walle J, Van Herzeele C, Raes A (2010) Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis? Drug Saf 33(4):261\u2013271. https:\/\/doi.org\/10.2165\/11319110-000000000-00000","journal-title":"Drug Saf"},{"issue":"24","key":"3297_CR48","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJM198606123142402","volume":"314","author":"RH Sterns","year":"1986","unstructured":"Sterns RH, Riggs JE, Schochet SS Jr (1986) Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 314(24):1535\u20131542. https:\/\/doi.org\/10.1056\/NEJM198606123142402","journal-title":"N Engl J Med"},{"issue":"1","key":"3297_CR49","doi-asserted-by":"publisher","first-page":"71.e1","DOI":"10.1016\/j.amjmed.2005.09.026","volume":"119","author":"B Renneboog","year":"2006","unstructured":"Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G (2006) Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119(1):71.e1-71.e8. https:\/\/doi.org\/10.1016\/j.amjmed.2005.09.026","journal-title":"Am J Med"},{"key":"3297_CR50","first-page":"443","volume":"48","author":"J Winberg","year":"1959","unstructured":"Winberg J (1959) The 24-hour true endogenous creatinine clearance in infants and children without renal disease. Acta Paediatr 48:443","journal-title":"Acta Paediatr"},{"issue":"6","key":"3297_CR51","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1097\/MPH.0000000000000185","volume":"36","author":"R Sharma","year":"2014","unstructured":"Sharma R, Stein D (2014) Hyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeries. J Pediatr Hematol Oncol 36(6):e371\u2013e375. https:\/\/doi.org\/10.1097\/MPH.0000000000000185","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"3297_CR52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00228-017-2386-0","volume":"74","author":"R Michelet","year":"2018","unstructured":"Michelet R, Dossche L, Van Herzeele C, Van Bocxlaer J, Vermeulen A, Walle JV (2018) Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis. Eur J Clin Pharmacol 74(3):297\u2013305. https:\/\/doi.org\/10.1007\/s00228-017-2386-0","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3297_CR53","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1464-410X.2006.05999.x","volume":"97","author":"JG Vande Walle","year":"2006","unstructured":"Vande Walle JG, Bogaert GA, Mattsson S, Schurmans T, Hoebeke P, Deboe V et al (2006) A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis. BJU Int 97(3):603\u2013609. https:\/\/doi.org\/10.1111\/j.1464-410X.2006.05999.x","journal-title":"BJU Int"},{"issue":"2","key":"3297_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2265.1993.tb00990.x","volume":"38","author":"A Fjellestad-Paulsen","year":"1993","unstructured":"Fjellestad-Paulsen A, H\u00f6glund P, Lundin S, Paulsen O (1993) Pharmacokinetics of 1-deamino-8-d-arginine vasopressin after various routes of administration in healthy volunteers. Clin Endocrinol 38(2):177\u2013182. https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb00990.x","journal-title":"Clin Endocrinol"},{"key":"3297_CR55","doi-asserted-by":"publisher","unstructured":"Williams T, Dunger D, Lyon C, Lewis R, Taylor F, Lightman S (1986) Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-d-arginine vasopressin. 1. Studies in adults and children. J Clin Endocrinol Metab 63(1):129\u201332. https:\/\/doi.org\/10.1210\/jcem-63-1-129","DOI":"10.1210\/jcem-63-1-129"},{"issue":"2","key":"3297_CR56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00431-013-2108-2","volume":"173","author":"P De Bruyne","year":"2014","unstructured":"De Bruyne P, De Guchtenaere A, Van Herzeele C, Raes A, Dehoorne J, Hoebeke P et al (2014) Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis. Eur J Pediatr 173(2):223\u2013228. https:\/\/doi.org\/10.1007\/s00431-013-2108-2","journal-title":"Eur J Pediatr"},{"issue":"3","key":"3297_CR57","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2125.1996.39914.x","volume":"42","author":"K Lam","year":"1996","unstructured":"Lam K, Wat M, Choi K, Ip T, Pang R, Kumana C (1996) Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-d-arginine vasopressin in adult patients with central diabetes insipidus. Br J Clin Pharmacol 42(3):379\u2013385. https:\/\/doi.org\/10.1046\/j.1365-2125.1996.39914.x","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"3297_CR58","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40262-019-00798-6","volume":"59","author":"R Michelet","year":"2020","unstructured":"Michelet R, Dossche L, Van Herzeele C, De Bruyne P, Gasthuys E, Van Bocxlaer J et al (2020) An integrated paediatric population PK\/PD analysis of dDAVP: how do pK differences translate to clinical outcomes? Clin Pharmacokinet 59(1):81\u201396. https:\/\/doi.org\/10.1007\/s40262-019-00798-6","journal-title":"Clin Pharmacokinet"},{"key":"3297_CR59","doi-asserted-by":"publisher","unstructured":"Thumfart J, Roehr CC, Kapelari K, Querfeld U, Eggert P, M\u00fcller D (2005) Desmopressin associated symptomatic hyponatremic hypervolemia in children. Are there predictive factors? J Urol 174(1):294\u20138. https:\/\/doi.org\/10.1097\/01.ju.0000161213.54024.7f","DOI":"10.1097\/01.ju.0000161213.54024.7f"},{"issue":"4","key":"3297_CR60","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/jcm3041163","volume":"3","author":"C Giuliani","year":"2014","unstructured":"Giuliani C, Peri A (2014) Effects of hyponatremia on the brain. J Clin Med 3(4):1163\u20131177. https:\/\/doi.org\/10.3390\/jcm3041163","journal-title":"J Clin Med"},{"issue":"2","key":"3297_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/nau.20168","volume":"25","author":"A Rembratt","year":"2006","unstructured":"Rembratt A, Riis A, Norgaard J (2006) Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourology and Urodynamics: Official Journal of the International Continence Society 25(2):105\u2013109. https:\/\/doi.org\/10.1002\/nau.20168","journal-title":"Neurourology and Urodynamics: Official Journal of the International Continence Society"},{"issue":"3","key":"3297_CR62","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/mds.870100318","volume":"10","author":"O Suchowersky","year":"1995","unstructured":"Suchowersky O, Furtado S, Rohs G (1995) Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson\u2019s disease. Movement disorders: Official journal of the Movement Disorder Society 10(3):337\u2013340. https:\/\/doi.org\/10.1002\/mds.870100318","journal-title":"Movement disorders: Official journal of the Movement Disorder Society"},{"issue":"12","key":"3297_CR63","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/archinte.1997.00440330027003","volume":"157","author":"I Singer","year":"1997","unstructured":"Singer I, Oster JR, Fishman LM (1997) The management of diabetes insipidus in adults. Arch Intern Med 157(12):1293\u20131301. https:\/\/doi.org\/10.1001\/archinte.1997.00440330027003","journal-title":"Arch Intern Med"},{"issue":"2","key":"3297_CR64","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1507\/endocrj.EJ13-0368","volume":"61","author":"H Arima","year":"2014","unstructured":"Arima H, Wakabayashi T, Nagatani T, Fujii M, Hirakawa A, Murase T et al (2014) Adipsia increases risk of death in patients with central diabetes insipidus. Endocr J 61(2):143\u2013148. https:\/\/doi.org\/10.1507\/endocrj.EJ13-0368","journal-title":"Endocr J"},{"issue":"6","key":"3297_CR65","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/archdischild-2019-318225","volume":"106","author":"L Dossche","year":"2021","unstructured":"Dossche L, Michelet R, De Bruyne P, Van Herzeele C, Gasthuys E, Rittig S et al (2021) Desmopressin oral lyophilisate in young children: new insights in pharmacokinetics and pharmacodynamics. Arch Dis Child 106(6):597\u2013602. https:\/\/doi.org\/10.1136\/archdischild-2019-318225","journal-title":"Arch Dis Child"},{"issue":"6","key":"3297_CR66","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.juro.2011.02.039","volume":"185","author":"A De Guchtenaere","year":"2011","unstructured":"De Guchtenaere A, Van Herzeele C, Raes A, Dehoorne J, Hoebeke P, Van Laecke E et al (2011) Oral lyophylizate formulation of desmopressin: superior pharmacodynamics compared to tablet due to low food interaction. J Urol 185(6):2308\u20132313. https:\/\/doi.org\/10.1016\/j.juro.2011.02.039","journal-title":"J Urol"},{"issue":"6","key":"3297_CR67","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1210\/jc.2013-4411","volume":"99","author":"K Juul","year":"2014","unstructured":"Juul K, Schroeder M, Rittig S, N\u00f8rgaard J (2014) National Surveillance of Central Diabetes Insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients. J Clin Endocrinol Metab 99(6):2181\u20132187. https:\/\/doi.org\/10.1210\/jc.2013-4411","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"3297_CR68","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1742-1241.2007.01493.x","volume":"61","author":"H Lottmann","year":"2007","unstructured":"Lottmann H, Froeling F, Alloussi S, El-Radhi A, Rittig S, Riis A et al (2007) A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis. Int J Clin Pract 61(9):1454\u20131460. https:\/\/doi.org\/10.1111\/j.1742-1241.2007.01493.x","journal-title":"Int J Clin Pract"},{"issue":"9","key":"3297_CR69","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00431-013-1992-9","volume":"172","author":"KV Juul","year":"2013","unstructured":"Juul KV, Van Herzeele C, De Bruyne P, Goble S, Walle JV, N\u00f8rgaard JP (2013) Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis. Eur J Pediatr 172(9):1235\u20131242. https:\/\/doi.org\/10.1007\/s00431-013-1992-9","journal-title":"Eur J Pediatr"},{"key":"3297_CR70","doi-asserted-by":"publisher","unstructured":"Arima H, Oiso Y, Juul KV, N\u00f8rgaard JP (2013) Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study. Endocr J EJ13\u20130165. https:\/\/doi.org\/10.1507\/endocrj.EJ13-0165","DOI":"10.1507\/endocrj.EJ13-0165"},{"key":"3297_CR71","doi-asserted-by":"publisher","unstructured":"Murakami T, Hatoko T, Nambu T, Matsuda Y, Matsuo K, Yonemitsu S et al (2014) Desmopressin orally disintegrating tablet in Japanese patients with central diabetes insipidus: A retrospective study of switching from intranasal desmopressin. Endocr J EJ14\u20130097. https:\/\/doi.org\/10.1507\/endocrj.EJ14-0097","DOI":"10.1507\/endocrj.EJ14-0097"},{"issue":"10","key":"3297_CR72","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1210\/jc.2013-2326","volume":"98","author":"Y Oiso","year":"2013","unstructured":"Oiso Y, Robertson GL, N\u00f8rgaard JP, Juul KV (2013) Treatment of neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 98(10):3958\u20133967. https:\/\/doi.org\/10.1210\/jc.2013-2326","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3297_CR73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12020-011-9492-z","volume":"40","author":"KV Juul","year":"2011","unstructured":"Juul KV, Bichet DG, N\u00f8rgaard JP (2011) Desmopressin duration of antidiuretic action in patients with central diabetes insipidus. Endocrine 40(1):67\u201374. https:\/\/doi.org\/10.1007\/s12020-011-9492-z","journal-title":"Endocrine"},{"issue":"4","key":"3297_CR74","first-page":"155","volume":"13","author":"B Larijani","year":"2005","unstructured":"Larijani B, Tabatabaei O, Soltani A, Taheri E, Pajouhi M, Bastanhagh M-H et al (2005) Comparison of desmopressin (DDAVP) tablet and intranasal spray in the treatment of central diabetes insipidus. DARU J Pharm Sci 13(4):155\u2013159","journal-title":"DARU J Pharm Sci"},{"key":"3297_CR75","unstructured":"Nilsson A, Lindner H, Wittendorff J (2019) inventors; Ferring B.V., assignee. Pharmaceutical formulations of desmopressin. United States patent US10307459B2"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03297-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-022-03297-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03297-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T08:04:22Z","timestamp":1652515462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-022-03297-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3297"],"URL":"https:\/\/doi.org\/10.1007\/s00228-022-03297-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"8 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}